Swiss biotech Veraxa to list on Nasdaq in $1.64 billion SPAC deal
23 Apr 2025 //
REUTER
Xlife Sciences AG Announces Potential FUSE-AI GmbH Acquisition
23 Dec 2024 //
PHARMAWEB
Xlife Sciences AG Announces Veraxa Biotech NASDAQ Listing Plans
16 Dec 2024 //
PHARMAWEB
Xlife Sciences Announces FUSE-AI Listing on Stock Exchange in 2025
21 Nov 2024 //
PHARMAWEB
Xlife Sciences Announces Strategic Merger Between palleos&& OCT Clinical
27 May 2024 //
PHARMIWEB
Xlife Sciences strengthens sustainability activities with ESG strategy
20 Sep 2022 //
YAHOO
Xlife Sciences AG: Successful License Deal with Vitese Trading GmbH
07 Oct 2021 //
BIOSPACE